Cavanaugh to Replace Taubert as J&J's Pharma Head

Cavanaugh to replace Taubert as J&J's pharma head

Jennifer Taubert will hand over the reins of Johnson & Johnson's Innovative Medicines division to Tom Cavanaugh after she retires on 1st September.

J&J pharma leader to retire; Krystal slumps on gene therapy miss

Jennifer Taubert will step down after a lengthy run leading J&J’s pharmaceutical business. Elsewhere, pricing issues hampered what Wall Street analysts view as an otherwise strong gene therapy launch.

Jennifer Taubert announces retirement from J&J; Takeda's global TYK2 leader exits

→ One of the most influential pharma execs at Johnson & Johnson is retiring. Jennifer Taubert, the worldwide chair of Johnson & Johnson Innovative Medicine, will hand the reins to Tom ...